-
1
-
-
77953615306
-
Curcumin as a therapeutic agent: The evidence from in vitro, animal and human studies
-
Epstein J, Sanderson IR, Macdonald TT. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 2010;103:1545-1557.
-
(2010)
Br J Nutr
, vol.103
, pp. 1545-1557
-
-
Epstein, J.1
Sanderson, I.R.2
Macdonald, T.T.3
-
2
-
-
73349094986
-
Curcumin and cancer cells: How many ways can curry kill tumor cells selectively?
-
Ravindran J, Prasad S, Aggarwal BB. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 2009;11:495-510.
-
(2009)
AAPS J
, vol.11
, pp. 495-510
-
-
Ravindran, J.1
Prasad, S.2
Aggarwal, B.B.3
-
3
-
-
34347221946
-
Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP1 and NFkappaB transcription factors
-
Dhandapani KM, Mahesh VB, Brann DW. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP1 and NFkappaB transcription factors. J Neurochem 2007;102: 522-538.
-
(2007)
J Neurochem
, vol.102
, pp. 522-538
-
-
Dhandapani, K.M.1
Mahesh, V.B.2
Brann, D.W.3
-
4
-
-
36348937833
-
Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma
-
Liu E, Wu J, Cao W, Zhang J, Liu W, Jiang X, Zhang X. Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma. J Neurooncol 2007;85:263-270.
-
(2007)
J Neurooncol
, vol.85
, pp. 263-270
-
-
Liu, E.1
Wu, J.2
Cao, W.3
Zhang, J.4
Liu, W.5
Jiang, X.6
Zhang, X.7
-
5
-
-
63249086235
-
Curcumin blocks brain tumor formation
-
Purkayastha S, Berliner A, Fernando SS, Ranasinghe B, Ray I, Tariq H, Banerjee P. Curcumin blocks brain tumor formation. Brain Res 2009;1266:130-138.
-
(2009)
Brain Res
, vol.1266
, pp. 130-138
-
-
Purkayastha, S.1
Berliner, A.2
Fernando, S.S.3
Ranasinghe, B.4
Ray, I.5
Tariq, H.6
Banerjee, P.7
-
7
-
-
58149165086
-
Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway
-
Wang D, Veena MS, Stevenson K, Tang C, Ho B, Suh JD, Duarte VM, Faull KF, Mehta K, Srivatsan ES, Wang MB. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway. Clin Cancer Res 2008;14:6228-6236.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 6228-6236
-
-
Wang, D.1
Veena, M.S.2
Stevenson, K.3
Tang, C.4
Ho, B.5
Suh, J.D.6
Duarte, V.M.7
Faull, K.F.8
Mehta, K.9
Srivatsan, E.S.10
Wang, M.B.11
-
8
-
-
57849106304
-
An in vitro study of liposomal curcumin: Stability, toxicity and biological activity in human lymphocytes and epstein-barr virus-transformed human B-cells
-
Chen C, Johnston TD, Jeon H, Gedaly R, McHugh PP, Burke TG, Ranjan D. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. Int J Pharm 2009;366:133-139.
-
(2009)
Int J Pharm
, vol.366
, pp. 133-139
-
-
Chen, C.1
Johnston, T.D.2
Jeon, H.3
Gedaly, R.4
McHugh, P.P.5
Burke, T.G.6
Ranjan, D.7
-
9
-
-
80052911156
-
Curcumin loaded fibrinogen nanoparticles for cancer drug delivery
-
Rejinold NS, Muthunarayanan M, Chennazhi KP, Nair SV, Jayakumar R. Curcumin loaded fibrinogen nanoparticles for cancer drug delivery. J Biomed Nanotechnol 2011;7:521-534.
-
(2011)
J Biomed Nanotechnol
, vol.7
, pp. 521-534
-
-
Rejinold, N.S.1
Muthunarayanan, M.2
Chennazhi, K.P.3
Nair, S.V.4
Jayakumar, R.5
-
10
-
-
84867215002
-
Curcumin-loaded N, O-carboxymethyl chitosan nanoparticles for cancer drug delivery
-
June 28 http://dx.doi.org/10.1163/092050611X581534
-
Anitha A, Maya S, Deepa N, Chennazhi KP, Nair SV, Jayakumar R. Curcumin-loaded N, O-carboxymethyl chitosan nanoparticles for cancer drug delivery. J Biomater Sci Polym Ed. 2011 June 28. Available at: http://dx.doi.org/10.1163/092050611X581534.
-
(2011)
J Biomater Sci Polym Ed.
-
-
Anitha, A.1
Maya, S.2
Deepa, N.3
Chennazhi, K.P.4
Nair, S.V.5
Jayakumar, R.6
-
11
-
-
67849099105
-
The application of poly(glycerol-sebacate) as biodegradable drug carrier
-
Sun ZJ, Chen C, Sun MZ, Ai CH, Lu XL, Zheng YF, Yang BF, Dong DL. The application of poly(glycerol-sebacate) as biodegradable drug carrier. Biomaterials 2009;30:5209-5214.
-
(2009)
Biomaterials
, vol.30
, pp. 5209-5214
-
-
Sun, Z.J.1
Chen, C.2
Sun, M.Z.3
Ai, C.H.4
Lu, X.L.5
Zheng, Y.F.6
Yang, B.F.7
Dong, D.L.8
-
12
-
-
73549103369
-
Glycolic acid modulates the mechanical property and degradation of poly(glycerol, sebacate, glycolic acid)
-
Sun ZJ, Wu L, Huang W, Chen C, Chen Y, Lu XL, Zhang XL, Yang BF, Dong DL. Glycolic acid modulates the mechanical property and degradation of poly(glycerol, sebacate, glycolic acid). J Biomed Mater Res A. 2010;92:332-339.
-
(2010)
J Biomed Mater Res A.
, vol.92
, pp. 332-339
-
-
Sun, Z.J.1
Wu, L.2
Huang, W.3
Chen, C.4
Chen, Y.5
Lu, X.L.6
Zhang, X.L.7
Yang, B.F.8
Dong, D.L.9
-
13
-
-
84863399427
-
The polycondensing temperature rather than time determines the degradation and drug release of poly(glycerol-sebacate) doped with 5-fluorouracil
-
Sun ZJ, Sun CW, Sun B, Lu XL, Dong DL. The polycondensing temperature rather than time determines the degradation and drug release of poly(glycerol-sebacate) doped with 5-fluorouracil. J Biomater Sci Polym Ed 2012;23:833-841.
-
(2012)
J Biomater Sci Polym Ed
, vol.23
, pp. 833-841
-
-
Sun, Z.J.1
Sun, C.W.2
Sun, B.3
Lu, X.L.4
Dong, D.L.5
-
14
-
-
84862910286
-
A poly(glycerol-sebacate-(5-fluorouracil-1-acetic acid)) polymer with potential use for cancer therapy
-
Sun ZJ, Sun B, Sun CW, Wang LB, Xie X, Ma WC, Lu XL, Dong DL. A poly(glycerol-sebacate-(5-fluorouracil-1-acetic acid)) polymer with potential use for cancer therapy. J Bioact Compat Polym 2012;27:18-30.
-
(2012)
J Bioact Compat Polym
, vol.27
, pp. 18-30
-
-
Sun, Z.J.1
Sun, B.2
Sun, C.W.3
Wang, L.B.4
Xie, X.5
Ma, W.C.6
Lu, X.L.7
Dong, D.L.8
-
15
-
-
77249166580
-
Incorporating BCNU wafers into Malignant glioma treatment: European case studies
-
Balossier A, Dörner L, Emery E, Heese O, Mehdorn HM, Menei P, Singh J. Incorporating BCNU wafers into malignant glioma treatment: European case studies. Clin Drug Investig 2010;30:195-204.
-
(2010)
Clin Drug Investig
, vol.30
, pp. 195-204
-
-
Balossier, A.1
Dörner, L.2
Emery, E.3
Heese, O.4
Mehdorn, H.M.5
Menei, P.6
Singh, J.7
|